{"id":383908,"date":"2025-10-14T14:50:00","date_gmt":"2025-10-14T12:50:00","guid":{"rendered":"https:\/\/group-gac.com\/?p=383908"},"modified":"2025-10-16T17:22:59","modified_gmt":"2025-10-16T15:22:59","slug":"etudes-cliniques-dispositifs-medicaux-cir","status":"publish","type":"post","link":"https:\/\/group-gac.com\/en\/clinical-studies-medical-devices-cir\/","title":{"rendered":"Clinical trials and medical devices: what really qualifies for the CIR"},"content":{"rendered":"
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Why is this webinar a must for healthcare professionals?<\/h2>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Did you know that\u2019healthcare industry<\/a> is the 3\u1d49 die to benefit from the Research Tax Credit <\/strong>? In 2021, it represented 759 M\u20ac receivable<\/strong>, or 11.1 % of total national receivables<\/strong> (source: MESR). Visit CIR<\/a> is therefore a a major source of funding for R&D in the sector. <\/strong><\/p>

But you still need to know which studies and activities are really eligible in a context of tightened tax controls and the Finance Act 2025, which restricts the basis for calculating the scheme<\/strong>...<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t\t

Why take part in this webinar?<\/h2>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Clinical and epidemiological studies and the development of medical devices<\/strong> raise many questions about their eligibility for the CIR. The boundaries between eligible and ineligible activities are sometimes blurred, and mistakes can be costly.<\/p>

In this webinar, our experts will help you to sorting out the truth from the falsehood<\/strong> and adopt a clear methodology for secure your CIR declarations<\/strong> and make it a sustainable lever for financing your R&D.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t

In the program :<\/h2>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
  • Conditions of eligibility for your clinical trials (phases I to IV)<\/strong>, epidemiological studies<\/strong> and development of your medical devices<\/strong>.<\/li>
  • Focus on eligible and non-eligible activities<\/strong> (protocol, feasibility, recruitment, data collection and processing).<\/li>
  • Eligibility criteria for personnel involved<\/strong> (researchers, clinicians, data managers, etc.).<\/li>
  • Best practices for securing your CIR<\/strong> thanks to an analysis of legal texts, the CIR Guide and our feedback.<\/li><\/ul>

    A question and answer session<\/strong> will close the presentation. You can submit your questions via the registration form.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

    \n\t\t
    \n\t\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t

    Watch the replay of our webinar!<\/h3>\t\t\t\t<\/div>\n\t\t\t\t
    \n\t\t\t\t\t\t\t